PHARMORIX SYMFLORIZ-35 CAPSULE
PHARMORIX SYMFLORIZ-35 CAPSULE : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL21106090NC
- Type
- Health supplement
- Published status
- PRODUCT APPROVED
- Licence holder
- PHARMORIX (M) SDN. BHD.
- Manufacturer
- BELIVE HEALTHCARE SDN. BHD.
- Registration period starting
- 2026-10-28
- Published validity end
- 2031-10-28
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| LACTOBACILLUS REUTERI | LACTOBACILLUS REUTERI[100 mg,480 mg] | Not identified |
| FRUCTOOLIGOSACCHARIDES | FRUCTOOLIGOSACCHARIDES[100 mg,480 mg] | Not identified |
| LACTOBACILLUS RHAMNOSUS | LACTOBACILLUS RHAMNOSUS[45 mg,480 mg] | Not identified |
| BIFIDOBACTERIUM LONGUM | BIFIDOBACTERIUM LONGUM[12.5 mg,480 mg] | Not identified |
| LACTOBACILLUS CASEI | LACTOBACILLUS CASEI[15 mg,480 mg] | Not identified |
| LACTOBACILLUS GASSERI | LACTOBACILLUS GASSERI[15 mg,480 mg] | Not identified |
| LACTOBACILLUS PLANTARUM | LACTOBACILLUS PLANTARUM[15 mg,480 mg] | Not identified |
| BIFIDOBACTERIUM BREVE | BIFIDOBACTERIUM BREVE[5 mg,480 mg] | Not identified |
| LACTOBACILLUS PARACASEI SPP. PARACASEI | LACTOBACILLUS PARACASEI SPP. PARACASEI[5 mg,480 mg] | Not identified |
| BIFIDOBACTERIUM BIFIDUM | BIFIDOBACTERIUM BIFIDUM[5 mg,480 mg] | Not identified |
| STREPTOCOCCUS THERMOPHILUS | STREPTOCOCCUS THERMOPHILUS[5 mg,480 mg] | Not identified |
| LACTOBACILLUS ACIDOPHILUS | LACTOBACILLUS ACIDOPHILUS[5 mg,480 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- LACTOBACILLUS REUTERI[100 mg,480 mg],FRUCTOOLIGOSACCHARIDES[100 mg,480 mg],LACTOBACILLUS RHAMNOSUS[45 mg,480 mg],BIFIDOBACTERIUM LONGUM[12.5 mg,480 mg],LACTOBACILLUS CASEI[15 mg,480 mg],LACTOBACILLUS GASSERI[15 mg,480 mg],LACTOBACILLUS PLANTARUM[15 mg,480 mg],BIFIDOBACTERIUM BREVE[5 mg,480 mg],LACTOBACILLUS PARACASEI SPP. PARACASEI[5 mg,480 mg],BIFIDOBACTERIUM BIFIDUM[5 mg,480 mg],STREPTOCOCCUS THERMOPHILUS[5 mg,480 mg],LACTOBACILLUS ACIDOPHILUS[5 mg,480 mg]
- Valid until
- 2031-10-28
- Registration date
- 2026-10-28
- Published description
- HEALTH SUPPLEMENT
- Licence holder
- PHARMORIX (M) SDN. BHD.
- Producer
- BELIVE HEALTHCARE SDN. BHD.
- Published name
- PHARMORIX SYMFLORIZ-35 CAPSULE
- Published reference
- 202108135860N
- Registration number
- MAL21106090NC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL21106090NC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.